Imuran and Gilenya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imuran (azathioprine) and Gilenya (fingolimod). Common drug interactions include depressed mood among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Imuran and Gilenya. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.

What is Gilenya?

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 111,893 Gilenya users. Check the latest studies of Gilenya.

On Jul, 26, 2026

29 people who take Imuran and Gilenya together, and have interactions are studied.

What are the common drug interactions of Imuran and Gilenya, by gender? *:

female:

Depressed mood
Drug ineffective
Dysstasia (difficulty in standing)
Erythema (redness of the skin)
Heart rate decreased
Influenza
Influenza like illness
Menstruation irregular
Neck pain
Platelet count decreased

male:

White blood cell count decreased
Arterial disorder
Viral infection
Alanine aminotransferase increased
Anaemia postoperative
Aspartate aminotransferase increased
Blood pressure increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Chest pain

What are the common drug interactions of Imuran and Gilenya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Contusion (a type of hematoma of tissue in which capillaries)
Weight decreased
White blood cell count decreased

20-29:

Diplopia (double vision)
Pain
Anaemia (lack of blood)
Ataxia (loss of full control of bodily movements)
Balance disorder
Blindness
Blood calcium decreased
Burning sensation
Dizziness
Dry mouth

30-39:

Pneumonia
White blood cell count decreased
Blood pressure decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Chest pain
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Colitis (inflammation of colon)
Dizziness
Dyspnoea (difficult or laboured respiration)

40-49:

Gamma-glutamyltransferase increased
White blood cell count decreased
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood cholesterol increased
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Depression
Eye pruritus (eye itching)
Herpes zoster
Hyperlipidaemia (presence of excess lipids in the blood)
Low density lipoprotein increased (cholesterol increased in blood)

50-59:

Nausea (feeling of having an urge to vomit)
Vomiting
Cystoid macular oedema (fluid accumulation after cataract surgery)
Intraocular pressure increased
Vision blurred
Abdominal discomfort
Burning sensation
Chills (felling of cold)
Fatigue (feeling of tiredness)
Oedema peripheral (superficial swelling)

60+:

Anaemia postoperative
Blood pressure increased
Lymphocyte count decreased
Nonspecific reaction (unspecified reaction)
White blood cell count decreased
Concomitant disease progression (progress in accompanying disease)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Diarrhoea
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Gastric antral vascular ectasia (blood vessels in the lining of the stomach become fragile and become prone to rupture and bleeding)

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 17.24%
Cough: 4 people, 13.79%
Osteoporosis (bones weak and more likely to break): 3 people, 10.34%
High Blood Pressure: 3 people, 10.34%
Oedema Peripheral (superficial swelling): 2 people, 6.90%
Dyslipidaemia (abnormal amount of lipids): 2 people, 6.90%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and Gilenya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously